These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26377248)

  • 21. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
    Dickson L; Menter A
    J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of ustekinumab in palmoplantar pustulosis.
    Hegazy S; Konstantinou MP; Bulai Livideanu C; Tauber M; Uthurriague C; Paul C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):e204-e206. PubMed ID: 29194805
    [No Abstract]   [Full Text] [Related]  

  • 24. Psoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab.
    Raposo I; Carvalho C; Bettencourt A; Da Silva BM; Leite L; Selores M; Torres T
    Eur J Dermatol; 2017 Oct; 27(5):528-530. PubMed ID: 29084639
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of ustekinumab in a psoriasis patient with human T-cell leukemia/lymphotropic virus type 1 infection.
    Kazama M; Umezawa Y; Itoh M; Nobeyama Y; Ito T; Kikuchi S; Yanaba K; Asahina A; Nakagawa H; Ogasawara Y
    J Dermatol; 2017 Nov; 44(11):1334-1335. PubMed ID: 27864824
    [No Abstract]   [Full Text] [Related]  

  • 26. Ustekinumab for the treatment of psoriasis: an evidence update.
    Yiu ZZ; Warren RB
    Semin Cutan Med Surg; 2018 Sep; 37(3):143-147. PubMed ID: 30215630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA).
    Bonekamp N; Caorsi R; Viglizzo GM; Graaf M; Minoia F; Grossi A; Picco P; Ceccherini I; Frenkel J; Gattorno M
    Ann Rheum Dis; 2018 Aug; 77(8):1241-1243. PubMed ID: 28866646
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.
    Prieto-Pérez R; Llamas-Velasco M; Cabaleiro T; Solano-López G; Márquez B; Román M; Ochoa D; Talegón M; Daudén E; Abad-Santos F
    Pharmacogenomics; 2017 Jan; 18(2):157-164. PubMed ID: 27977334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study.
    Youn SW; Kim BR; Cho S; Seo SJ; Lee ES; Roh JY; Choi GS; Lee MG;
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e298-e299. PubMed ID: 27976465
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.
    Rouse NC; Farhangian ME; Wehausen B; Feldman SR
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):877-84. PubMed ID: 26488186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab.
    Goh SW; Jamil A; Nor NM; Cader RA; Shaharir SS
    Indian J Dermatol Venereol Leprol; 2020; 86(1):68-70. PubMed ID: 31823905
    [No Abstract]   [Full Text] [Related]  

  • 33. Inverse psoriasis treated with ustekinumab.
    Campos MA; Varela P; Baptista A; Moreira AI
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester.
    Sheeran C; Nicolopoulos J
    Australas J Dermatol; 2014 Aug; 55(3):235-6. PubMed ID: 25117169
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.
    Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V
    Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept.
    Brodmerkel C; Li K; Garcet S; Hayden K; Chiricozzi A; Novitskaya I; Fuentes-Duculan J; Suarez-Farinas M; Campbell K; Krueger JG
    J Allergy Clin Immunol; 2019 May; 143(5):1965-1969. PubMed ID: 30703387
    [No Abstract]   [Full Text] [Related]  

  • 37. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
    Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
    Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
    [No Abstract]   [Full Text] [Related]  

  • 38. A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.
    Nogueira M; Reis J; Abreu M; Coelho A; Reis CF; Machado S
    Pediatr Dermatol; 2023; 40(6):1104-1106. PubMed ID: 37219506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting.
    Menting SP; van den Reek JM; Baerveldt EM; de Jong EM; Prens EP; Lecluse LL; Wolbink GJ; Van der Kleij D; Spuls PI; Rispens T
    Br J Dermatol; 2015 Sep; 173(3):855-7. PubMed ID: 25865153
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab.
    Nogueira M; Selores M; Torres T
    Eur J Dermatol; 2021 Jun; 31(3):429-431. PubMed ID: 34309535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.